Cambridge Isotope Laboratories, Inc.
PharmaceuticalsManufacturing & Production
Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer of stable isotopes and stable isotope-labeled compounds. With over 600 employees and laboratories in five countries, CIL specializes in the process of labeling biochemical and organic compounds with highly enriched, stable (nonradioactive) isotopes of carbon, hydrogen, nitrogen and oxygen. Our chemists substitute common atoms (e.g., 1H, 12C, 14N, 16O) with rare, highly valued isotopes (e.g., 2H or D, 13C, 15N, 18O) so that the final product can be readily measured or traced using mass spectrometry (MS) or nuclear magnetic resonance (NMR). CIL’s products are utilized in laboratories, medical, government and academic research centers and health care facilities worldwide.
We are proud that CIL products have contributed to medical advancements in cancer research, drug development, environmental analysis, and medical diagnostic research.
CIL World Headquarters and cGMP Production Laboratories
moved into its new Tewksbury, MA, facility in the spring of 2013. As the new corporate headquarters, this 40,000-square-foot facility houses the executive team as well as sales, marketing, finance, regulatory affairs and cGMP production staff. In addition to corporate office space, the facility has a 10,000-square-foot state-of-the-art cGMP suite, which includes production laboratories, dedicated isolation rooms, a dedicated analytical laboratory, a packaging laboratory and a development laboratory.